Medicine
Chapter 7
Section 15.1
Neurology And Neuromuscular Services
Issue Date: April
19, 1983
Copyright: CPT only © 2006
American Medical Association (or such other date of publication
of CPT).
All Rights Reserved.
Revision: C-61,
April 17, 2020
1.0 CPT PROCEDURE
CODEs
20552, 20553, 95812 - 95999
2.0 HCPCS Procedure Code
J9310
3.0 DESCRIPTION
The diagnosis
and treatment of muscle and nerve disorders.
4.0 POLICY
4.1 Neurology
and neuromuscular services are covered.
4.2 The
Epley Canalith Repositioning Procedure (CRP) is covered for the
treatment of Benign Paroxysmal Positional Vertigo (BPPV) with an
effective date of June 13, 2012.
4.3 Off-label
use of rituximab may be considered for cost-sharing for the treatment
of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The
effective date is July 16, 2010.
4.4 Off-label
use of rituximab injections may be considered for cost-sharing for
the treatment of Stiff Person Syndrome. The effective date is March
31, 2005.
4.5 Off-label use of rituximab injections may
be considered for cost-sharing for the treatment of Multiple Sclerosis
(MS). The effective date is February 14, 2008.
5.0 Exclusions
5.1 Topographic
brain mapping (HCPCS S8040) is unproven.
5.2 Microcurrent Electrical Therapy (MET),
Cranial Electrotherapy Stimulation (CES), or any therapy that uses
the non-invasive application of low levels of microcurrent stimulation
to the head by means of external electrodes for the treatment of
anxiety, depression, insomnia, Post-Traumatic Stress Disorder (PTSD),
pain, or migraines and electrical stimulation devices used to apply
this therapy, are unproven.
5.3 Magnetic Resonance Guided High-Intensity
Focused Ultrasound Surgery (MRgFUS) (CPT 0398T) for the treatment
of essential tremor is unproven.
5.4 External
trigeminal nerve stimulation (eTNS),
also referred to as transcutaneous supraorbital neurostimulation (t-SNS),
for the prevention and/or treatment of migraines is unproven.
- END -